Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Meta Platforms Inc (META) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Meta Platforms Inc — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.66 (market cap $31.07B), while Meta Platforms Inc trades at $725.66 (market cap $1.94T). The key difference: Meta Platforms Inc is far larger — about 62.4× GE HealthCare Technologies Inc. Common Stock's market cap, and Meta Platforms Inc pays the higher dividend (0.28%). Which is the better fit depends on your goals.
| GEHC | META | |
|---|---|---|
Market Cap | $31.07B | $1.94T |
Volume | 3,443,020 | 22,627,792 |
Sector | Health | Media |
52-Week High | $88.16 | $777.59 |
52-Week Low | $59.48 | $525.72 |
Enterprise Value | $39.53B | $1.96T |
Dividend Yield | 0.23% | 0.28% |
Typical Hold Time | — | 128 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Meta Platforms (META) trades at $737.54, down 0.73% on the day, with strong bullish technical signals from moving averages and ADX indicators. The company demonstrates robust fundamentals with $201B revenue in 2025, 29.8% net margin, and consistent earnings beats in recent quarters. Recent AI developments including Muse Spark launch and a $21B CoreWeave deal highlight growth initiatives.
Wall Street maintains strong bullish sentiment with 80% buy ratings and $802.80 consensus target, representing 9% upside. Key risks include ongoing youth addiction litigation in Massachusetts and elevated capital expenditures for AI infrastructure. The stock presents growth potential through AI monetization but faces regulatory and execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Meta Platforms Inc
Meta Platforms Inc., doing business as Meta and previously known as Facebook Inc. It's a company that acts as a parent platform for Facebook, Messenger, Instagram, Whatsapp, Oculus and other subsidiaries. Among these platforms, Facebook is the number one social media platform in terms of the number of active users.
Read more on META →
